First Brands Group debt targeted by Apollo Global Management - report
Investing.com - Jefferies lowered its price target on Celanese (NYSE:CE) to $43.00 from $47.00 on Monday, while maintaining a Hold rating on the chemical company’s stock. The stock, currently trading at $48.73, has seen a significant decline of nearly 60% over the past year, according to InvestingPro data.
The firm reduced its 2025-2027 estimates for Celanese to reflect expected near-term volatility in the company’s performance.
Jefferies now anticipates that the cyclical recovery for Celanese will be delayed until 2027, later than previously forecast, and expects the eventual recovery to be more subdued than earlier projections.
The research firm cited elevated balance sheet risk as a key concern for the chemical manufacturer.
Jefferies indicated that significant stimulus, including at least two to three more interest rate cuts without offsetting policy shocks, along with evidence of competitor discipline, would be necessary to create a better entry point for investors. For deeper insights into Celanese’s financial health and valuation metrics, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers over 1,400 US stocks with detailed analysis and actionable intelligence.
In other recent news, Celanese has faced several analyst revisions due to various challenges impacting its business. RBC Capital has lowered its price target for Celanese to $45, citing weak near-term volume and production issues that could result in a significant decrease in earnings for the third quarter of 2025. BMO Capital also reduced its price target to $47, highlighting market pressures, particularly in China, Europe, and the U.S. acetic acid market. KeyBanc adjusted its price target to $70 following a disappointing second-quarter update, noting ongoing challenges with demand and pricing despite good cost management. BofA Securities decreased its target to $59, pointing to deteriorating demand and shortened order books in the summer months. CFRA took a more cautious stance, reducing its price target to $30, emphasizing concerns over Celanese’s high debt levels and tariff-related pressures. These recent developments reflect a cautious outlook from analysts across various firms, each pointing to specific challenges facing Celanese.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.